Fig. 6.
Emodin directly targets GSK-3β to accelerate PD-L1 degradation. A, B GSK-3β protein expression compared with that of GAPDH in tumor tissues, H22, Huh7, and LM3 cells after emodin treatment. C Exposure of H22, Huh7, and LM3 cells with GSK-3β inhibition (GSK-3βIB) to emodin. Western blot analysis was conducted to measure the expression levels of GSK-3β and PD-L1. D Overexpressing GSK-3β (GSK-3βOE) enhanced the inhibitory effects of emodin on PD-L1 protein expression in H22, Huh7, and LM3 cells. E Fluorescence images of LM3 cells that were stained with anti-GSK-3β (green), anti-PD-L1 (red), and DAPI (blue) (200 ×). The data are from three independent experiments (mean ± SD, *P < 0.05, **P < 0.01 vs. controls. #P < 0.05 vs. emodin group)